Tilaknagar Industries Q1 FY27 Revenue Surges 166% YoY to ₹1,046 Crore, First-Ever ₹1000 Crore+ Quarter
Tilaknagar Industries reported a record Q1 FY27 net revenue of ₹1,046 crore, up 166% YoY. Volumes surged 172% to 8.7 mn cases. EBITDA grew 166% to ₹148 crore (adjusted). PAT increased 52% to ₹76 crore (adjusted). The company expects continued growth driven by brand strength and premiumization initiatives.
The announcement details record financial performance, including the first-ever quarterly revenue crossing ₹1,000 crore, and substantial YoY growth in volumes and profitability. This signifies a major positive development for the company's financial standing and market position.
The company reported record-breaking revenue and significant year-on-year growth across key financial metrics like revenue, EBITDA, and PAT. Positive commentary from the MD regarding future growth and successful integration further supports a positive sentiment.
Tilaknagar Industries Limited (TI) announced its financial results for the quarter ended June 30, 2026, reporting its first-ever quarterly net revenue of over ₹1,000 crore. The company's net revenue from operations stood at ₹1,046 crore, marking a significant 166% year-on-year growth compared to ₹394 crore in the same period last year. Adjusted for subsidy, the net revenue was ₹1,026 crore, an increase of 189% YoY.
Consolidated volumes grew by an impressive 172% YoY to reach 8.7 million cases, with Mansion House Brandy (MHB) growing over 7% and Imperial Blue (IB) growing 18% quarter-on-quarter. On a quarter-on-quarter basis, total volumes rose by 9%.
EBITDA grew by 79% to ₹169 crore from ₹94 crore. Adjusted for subsidy income, EBITDA stood at ₹148 crore, a growth of 166% YoY, with a margin of 14.5%. The company noted that excluding the impact of inflationary pressures, the margin would have been approximately 17%.
Profit After Tax (PAT), excluding exceptional items and amortization related to the acquisition of Imperial Blue, increased by 9% to ₹96 crore. Adjusted for subsidy income, PAT increased by 52% YoY. The adjusted PAT margin was around 10% after considering inflationary pressures.
Mr. Amit Dahanukar, Chairman & Managing Director, commented on the performance, highlighting the successful integration of IB operations, with approximately 90% transitioned out of the Transition Services & Manufacturing Agreement (TSMA). He expressed confidence in delivering double-digit volume growth for the IB brand in FY27, as it crossed 2 million cases in both May and June. Despite inflationary pressures on packaging costs, the company expects margin expansion through cost optimization initiatives. Positive developments in the policy and regulatory environment, including the India-UK Free Trade Agreement and excise policy reforms in Karnataka, are expected to be beneficial.
TI reaffirmed its position as the largest domestic Prestige & Above (P&A) IMFL player and the third-largest P&A player in India. The company also launched its House of TI premium portfolio in West Bengal and its associate company, Spaceman Spirits Lab, makers of Samsara Gin, achieved 2.2x volume growth over Q1 FY26.
What to do with a filing like this
Tilaknagar Industries Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Tilaknagar Industries Limited. Read the original for the full detail.